RG
TWST icon

Redmile Group’s Twist Bioscience TWST Stock Holding History

Redmile Group’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-589,300
Closed -$26.7M – 89
2020
Q2 		$26.7M Sell
589,300
-900
-0.2% -$32.3K 0.49% 54
2020
Q1 		$18M Buy
+590,200
New +$15.9M 0.51% 47

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Redmile Group's TWST Position: Q3 2020 in Review

Redmile Group sold out of Twist Bioscience (TWST) in Q3 2020, closing a stake of 589,300 shares — an estimated $26.7M sold.

Redmile Group first reported a position in TWST in Q1 2020 and held it in 2 quarters. The position peaked at $26.7M in Q2 2020. 194 funds tracked by Wall St. Rank hold TWST as of Q3 2020.

  • Redmile Group reported no remaining Twist Bioscience position as of Q3 2020 after selling out during the quarter.
  • Redmile Group sold 589,300 Twist Bioscience shares in Q3 2020, an estimated $26.7M.
  • Redmile Group first reported a position in Twist Bioscience in Q1 2020 and held it in 2 quarters.
  • Redmile Group's Twist Bioscience position peaked at $26.7M in Q2 2020.
  • 194 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2020.

Based on Redmile Group's 13F filing for Q3 2020, filed 16 Nov 2020.